Latest Content

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.

Experts analyze how Trump's drug pricing policies, including Most Favored Nation (MFN) and tariffs, reshape pharma markets and impact patient costs and access.

Speakers at AMCP Nexus 2025 reviewed the oncology pipeline, highlighting expanded indications and new therapies advancing innovation, access, and value.

This article provides insights into patterns of health care use following emergency department visits by high-need, high-cost patients with different types of California Medicaid primary care providers.

Ketogenic diets were linked to modest reductions in depressive symptoms, especially with ketone monitoring, while anxiety results remain unclear.

Patients with diabetic macular edema (DME) using faricimab had durable results after 1 year in real-world practice.

Clinicians may underassess the need for community-based palliative care among patients with dementia.

In the phase 3 BRAVE-AA-PEDS trial, baricitinib led to significant scalp, eyelash, and eyebrow hair regrowth at 1 year in adolescents with alopecia areata.

RPM may improve patient access to care, especially those with high-risk conditions, but not without a significant cost.